Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF Cyclosporine 0.1% Switch in Glaucoma OSD
NCT04673604Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- May 2018
- Primary completion
- Dec 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine in ocular surface disease (OSD), sponsored by Aristotle University of Thessaloniki. Started May 2018; status: completed.
02
Drugs
cyclosporine
03
Conditions
ocular surface disease (OSD)
Beyond the preview
Go deeper on NCT04673604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04673604.